Rosiglitazone, insulin treatment, and fasting correct defective activation of protein kinase C-zeta/lambda by insulin in vastus lateralis muscles and adipocytes of diabetic rats (Q43543575): Difference between revisions
Jump to navigation
Jump to search
Set a claim value: title (P1476): Rosiglitazone, insulin treatment, and fasting correct defective activation of protein kinase C-zeta/lambda by insulin in vastus lateralis muscles and adipocytes of diabetic rats |
Changed Asturian description: artículu científicu espublizáu en 2001, bot (details) |
||
| description / ast | description / ast | ||
artículu científicu | artículu científicu espublizáu en 2001 | ||
Latest revision as of 19:03, 9 March 2024
scientific article published in April 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rosiglitazone, insulin treatment, and fasting correct defective activation of protein kinase C-zeta/lambda by insulin in vastus lateralis muscles and adipocytes of diabetic rats |
scientific article published in April 2001 |
Statements
1 reference
Rosiglitazone, insulin treatment, and fasting correct defective activation of protein kinase C-zeta/lambda by insulin in vastus lateralis muscles and adipocytes of diabetic rats (English)
1 reference
Y Kanoh
1 reference
G Bandyopadhyay
1 reference
M P Sajan
1 reference
M L Standaert
1 reference
R V Farese
1 reference
1 April 2001
1 reference
1 reference
142
1 reference
4
1 reference
1595-1605
1 reference
Identifiers
1 reference
1 reference